AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
ETHYLENEDIAMINETETRAACETIC ACID (EDTA) IN HEPARIN
Authors: COYNE E MESSMORE HL WALENGA JM FAREED J WEHRMACHER WH
Citation: E. Coyne et al., ETHYLENEDIAMINETETRAACETIC ACID (EDTA) IN HEPARIN, Thrombosis research, 90(5), 1998, pp. 245-246
EFFECT OF ANTIPLATELET AGENTS ON THE HEPARIN-INDUCED THROMBOCYTOPENICSERUM-INDUCED ACTIVATION OF PLATELETS AS MEASURED BY FLOW-CYTOMETRY
Authors: WALENGA JM JESKE W HAAS S MESSMORE HL BAKHOS M
Citation: Jm. Walenga et al., EFFECT OF ANTIPLATELET AGENTS ON THE HEPARIN-INDUCED THROMBOCYTOPENICSERUM-INDUCED ACTIVATION OF PLATELETS AS MEASURED BY FLOW-CYTOMETRY, Clinical chemistry, 44, 1998, pp. 238-238
TICLOPIDINE AND CLOPIDOGREL - DO THEY HAVE DIRECT VASCULAR EFFECTS
Authors: WEHRMACHER WH MESSMORE HL BICK RL FAREED J
Citation: Wh. Wehrmacher et al., TICLOPIDINE AND CLOPIDOGREL - DO THEY HAVE DIRECT VASCULAR EFFECTS, Clinical and applied thrombosis/hemostasis, 3(4), 1997, pp. 225-225
EX-VIVO HEPARIN LEVELS COMPARED WITH APTT RATIOS IN HEPARINIZED PATIENTS - RESULTS UTILIZING 10 DIFFERENT APTT REAGENTS
Authors: FABBRINI N MESSMORE HL BALBALE S PANZA L RUHLAND S CROSBY T EDWARDS B BIRD ML WEHRMACHER W BRACE L
Citation: N. Fabbrini et al., EX-VIVO HEPARIN LEVELS COMPARED WITH APTT RATIOS IN HEPARINIZED PATIENTS - RESULTS UTILIZING 10 DIFFERENT APTT REAGENTS, Thrombosis and haemostasis, 1997, pp. 1153-1153
SENSITIVITY OF 5 LATEX AGGLUTINATION-TEST KITS FOR D-DIMER AS COMPARED WITH AN ENZYME-IMMUNOASSAY TEST KIT
Authors: FABBRINI N RUHLAND S MESSMORE HL BIRD ML BALBALE S CROSBY T EDWARDS B WEHRMACHER W BRACE L
Citation: N. Fabbrini et al., SENSITIVITY OF 5 LATEX AGGLUTINATION-TEST KITS FOR D-DIMER AS COMPARED WITH AN ENZYME-IMMUNOASSAY TEST KIT, Thrombosis and haemostasis, 1997, pp. 1789-1789
VALIDITY OF THE LABORATORY METHODS FOR THE DIAGNOSIS OF HIT - COMPARATIVE-STUDIES ON C-14 SEROTONIN RELEASE, ANTI-HEPARIN PLATELET FACTOR-4ANTIBODIES, PLATELET AGGREGOMETRY, LUMINESCENCE AGGREGOMETRY AND FLOWCYTOMETRIC METHODS
Authors: WALENGA JM JESKE W LEWIS BE FABBRINI N YANG L SZATKOWSKI E FASANELLA A HAAS S MESSMORE HL PIFARRE R
Citation: Jm. Walenga et al., VALIDITY OF THE LABORATORY METHODS FOR THE DIAGNOSIS OF HIT - COMPARATIVE-STUDIES ON C-14 SEROTONIN RELEASE, ANTI-HEPARIN PLATELET FACTOR-4ANTIBODIES, PLATELET AGGREGOMETRY, LUMINESCENCE AGGREGOMETRY AND FLOWCYTOMETRIC METHODS, Thrombosis and haemostasis, 1997, pp. 1840-1840
CLINICAL PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES ON ARGATROBAN TOOPTIMIZE THE ANTICOAGULANT DOSAGE IN INTERVENTIONAL CARDIOVASCULAR PROCEDURES
Authors: LEWIS BE IQBAL O HOPPENSTEADT D AHSAN A AHMAD S MESSMORE HL SCHWARZ RP WALENGA JM
Citation: Be. Lewis et al., CLINICAL PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES ON ARGATROBAN TOOPTIMIZE THE ANTICOAGULANT DOSAGE IN INTERVENTIONAL CARDIOVASCULAR PROCEDURES, Thrombosis and haemostasis, 1997, pp. 2010-2010
PRE-EXISTENCE OF ANTI-PF4-HEPARIN ANTIBODIES IN PATIENTS NOT EXPOSED TO HEPARINS - RELEVANCE TO CLINICAL THROMBOCYTOPENIA
Authors: LEITZ H WALENGA JM FABBRINI N LEWIS BE FASANELLA A MESSMORE HL PIFARRE R
Citation: H. Leitz et al., PRE-EXISTENCE OF ANTI-PF4-HEPARIN ANTIBODIES IN PATIENTS NOT EXPOSED TO HEPARINS - RELEVANCE TO CLINICAL THROMBOCYTOPENIA, Thrombosis and haemostasis, 1997, pp. 2302-2302
FUNCTIONAL FACTOR-X LEVELS AS A MEANS TO ASSESS THE REVEL OF ORAL ANTICOAGULATION IN PATIENTS RECEIVING ANTITHROMBIN DRUGS
Authors: HOPPENSTEADT D LEWIS BE FABBRINI N LEITZ H FASANELLA A MESSMORE HL SCHWARZ R WALENGA JM
Citation: D. Hoppensteadt et al., FUNCTIONAL FACTOR-X LEVELS AS A MEANS TO ASSESS THE REVEL OF ORAL ANTICOAGULATION IN PATIENTS RECEIVING ANTITHROMBIN DRUGS, Thrombosis and haemostasis, 1997, pp. 2607-2607
PLASMA THROMBOMODULIN LEVEL AS A PREDICTOR OF HEMORRHAGIC (AND THROMBOTIC) EVENTS IN PATIENTS ON LONG-TERM ANTICOAGULANT TREATMENT
Authors: FAREED J MESSMORE HL
Citation: J. Fareed et Hl. Messmore, PLASMA THROMBOMODULIN LEVEL AS A PREDICTOR OF HEMORRHAGIC (AND THROMBOTIC) EVENTS IN PATIENTS ON LONG-TERM ANTICOAGULANT TREATMENT, Circulation, 96(9), 1997, pp. 2765-2768
CROSS-REACTIVITY OF LOW-MOLECULAR-WEIGHT HEPARINS WITH ANTI-PF4-HEPARIN ANTIBODIES AS MEASURED USING THE SEROTONIN RELEASE ASSAY
Authors: JESKE WP HAAS S WOOD J FASANELLA A MESSMORE HL AMIRAL J BAKHOS M WALENGA JM
Citation: Wp. Jeske et al., CROSS-REACTIVITY OF LOW-MOLECULAR-WEIGHT HEPARINS WITH ANTI-PF4-HEPARIN ANTIBODIES AS MEASURED USING THE SEROTONIN RELEASE ASSAY, Blood, 90(10), 1997, pp. 2989-2989
LOW-MOLECULAR-WEIGHT HEPARINS - VALUABLE NEW HEPARIN SUBSTITUTES
Authors: MESSMORE HL WEHRMACHER WH
Citation: Hl. Messmore et Wh. Wehrmacher, LOW-MOLECULAR-WEIGHT HEPARINS - VALUABLE NEW HEPARIN SUBSTITUTES, Clinical and applied thrombosis/hemostasis, 2, 1996, pp. 1-3
CLINICAL AND LABORATORY VALIDATION OF VARIOUS TESTS FOR THE DIAGNOSISOF HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
Authors: FAREED J WALENGA JM JESKE W KOZA M HOPPENSTEADT D RAIBLE M MESSMORE HL
Citation: J. Fareed et al., CLINICAL AND LABORATORY VALIDATION OF VARIOUS TESTS FOR THE DIAGNOSISOF HEPARIN-INDUCED THROMBOCYTOPENIA (HIT), The FASEB journal, 10(3), 1996, pp. 2553-2553
CLINICAL AND LABORATORY VALIDATION OF VARIOUS TESTS FOR THE DIAGNOSISOF HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
Authors: FAREED J WALENGA JM JESKE W KOZA MJ HOPPENSTEADT DA RAIBLE M MESSMORE HL BREDDIN K
Citation: J. Fareed et al., CLINICAL AND LABORATORY VALIDATION OF VARIOUS TESTS FOR THE DIAGNOSISOF HEPARIN-INDUCED THROMBOCYTOPENIA (HIT), Clinical chemistry, 42(6), 1996, pp. 223-223
OVERWHELMING SEPSIS AND BLEEDING IN A PREVIOUSLY SPLENECTOMIZED PATIENT
Authors: MESSMORE HL NIJM W GAWLIK G FAHEY P
Citation: Hl. Messmore et al., OVERWHELMING SEPSIS AND BLEEDING IN A PREVIOUSLY SPLENECTOMIZED PATIENT, Clinical and applied thrombosis/hemostasis, 1(1), 1995, pp. 80-84
EFFECT OF FREEZE - THAWING ON HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN LEVELS IN PLATELET POOR PLASMA
Authors: MESSMORE HL FARID S FABBRINI N
Citation: Hl. Messmore et al., EFFECT OF FREEZE - THAWING ON HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN LEVELS IN PLATELET POOR PLASMA, Thrombosis and haemostasis, 73(6), 1995, pp. 1242-1242
VON-WILLEBRAND-FACTOR LEVELS BEFORE AND DURING CORONARY-ARTERY ANGIOPLASTY CORRELATION WITH ACUTE CORONARY SYNDROMES POST-ANGIOPLASTY
Authors: HALLE AA JOHNSON SA SCANLON PJ LEYA F MCKIERNAN T FISHER S FARID S MESSMORE HL
Citation: Aa. Halle et al., VON-WILLEBRAND-FACTOR LEVELS BEFORE AND DURING CORONARY-ARTERY ANGIOPLASTY CORRELATION WITH ACUTE CORONARY SYNDROMES POST-ANGIOPLASTY, Thrombosis and haemostasis, 73(6), 1995, pp. 1382-1382
UNIQUE BROAD-SPECTRUM SERINE-PROTEASE INHIBITOR IN A PATIENT WITH MULTIPLE-MYELOMA AND A THROMBOTIC DISORDER
Authors: MESSMORE HL FABBRINI N FARID S MORGAN J MCLEAN K TUEN B BHOOPALAM N HOPPENSTEADT D
Citation: Hl. Messmore et al., UNIQUE BROAD-SPECTRUM SERINE-PROTEASE INHIBITOR IN A PATIENT WITH MULTIPLE-MYELOMA AND A THROMBOTIC DISORDER, Thrombosis and haemostasis, 73(6), 1995, pp. 1430-1430
MOLECULAR MARKERS OF HEMOSTATIC ACTIVATION - IMPLICATIONS IN THE DIAGNOSIS OF THROMBOSIS, VASCULAR, AND CARDIOVASCULAR DISORDERS
Authors: FAREED J BICK RL HOPPENSTEADT DA WALENGA JM MESSMORE HL BERMES EW
Citation: J. Fareed et al., MOLECULAR MARKERS OF HEMOSTATIC ACTIVATION - IMPLICATIONS IN THE DIAGNOSIS OF THROMBOSIS, VASCULAR, AND CARDIOVASCULAR DISORDERS, Clinics in laboratory medicine, 15(1), 1995, pp. 39-61
THE ANTICOAGULANT EFFECT OF HEPARIN IS ALTERED BY A PENTASACCHARIDE
Authors: MESSMORE HL FARID S FABBRINI N
Citation: Hl. Messmore et al., THE ANTICOAGULANT EFFECT OF HEPARIN IS ALTERED BY A PENTASACCHARIDE, Blood, 86(10), 1995, pp. 3514-3514
EFFECT OF FACTOR-VIII LEVELS ON THE CALCIUM THROMBIN TIME (CATT) OF HEPARINIZED NORMAL PLASMA
Authors: MESSMORE HL FARID S FABBRINI N
Citation: Hl. Messmore et al., EFFECT OF FACTOR-VIII LEVELS ON THE CALCIUM THROMBIN TIME (CATT) OF HEPARINIZED NORMAL PLASMA, Blood, 86(10), 1995, pp. 3515-3515
UTILITY OF THE HEPTEST AND A CHROMOGENIC SUBSTRATE METHOD TO ASSESS ANTICOAGULATION IN PATIENTS REFRACTORY TO HEPARINIZATION BY THE ACTIVATED PARTIAL THROMBOPLASTIN TIME METHOD
Authors: MESSMORE HL KOZA M FARID S WEHRMACHER WH
Citation: Hl. Messmore et al., UTILITY OF THE HEPTEST AND A CHROMOGENIC SUBSTRATE METHOD TO ASSESS ANTICOAGULATION IN PATIENTS REFRACTORY TO HEPARINIZATION BY THE ACTIVATED PARTIAL THROMBOPLASTIN TIME METHOD, Seminars in thrombosis and hemostasis, 20(4), 1994, pp. 351-352
MEDICAL ASSESSMENT OF BLEEDING IN THE SURGICAL PATIENT
Authors: MESSMORE HL GODWIN J
Citation: Hl. Messmore et J. Godwin, MEDICAL ASSESSMENT OF BLEEDING IN THE SURGICAL PATIENT, The Medical clinics of North America, 78(3), 1994, pp. 625-634
BIORHEOLOGY OF THE CARDIOVASCULAR-SYSTEM
Authors: SIEGLAFF C MESSMORE HL WALENGA JM WEHRMACHER WH
Citation: C. Sieglaff et al., BIORHEOLOGY OF THE CARDIOVASCULAR-SYSTEM, Journal of cardiovascular diagnosis and procedures, 11(2), 1993, pp. 97-103
WHOLE-BLOOD HEPTEST H(TM) MAY BE BETTER THAN THE WHOLE-BLOOD ACTIVATED CLOTTING TIME TO MONITOR ANTICOAGULATION IN PATIENTS UNDERGOING PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY OF THE CORONARY-ARTERIES
Authors: MESSMORE HL JOHNSON SA SCANLON PJ LEYA F MCKIERNAN TL FISHER SA FARID S KOZA M HALLE AA
Citation: Hl. Messmore et al., WHOLE-BLOOD HEPTEST H(TM) MAY BE BETTER THAN THE WHOLE-BLOOD ACTIVATED CLOTTING TIME TO MONITOR ANTICOAGULATION IN PATIENTS UNDERGOING PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY OF THE CORONARY-ARTERIES, Thrombosis and haemostasis, 69(6), 1993, pp. 865-865
Risultati: 1-25 | 26-31